Clinical Trials Browser

Approved for marketing × Lapatinib × Clear all

NCT00338247 2016-04-06

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Approved for marketing

Breast Neoplasms, Neoplasm Metastasis